iBio
IBIO
#10296
Rank
A$76.26 M
Marketcap
A$1.08
Share price
-4.00%
Change (1 day)
-35.72%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): A-$1.17

According to iBio's latest financial reports the company's current EPS (TTM) is A-$1.11. In 2025 the company made an earnings per share (EPS) of A-$2.59 an increase over its 2024 EPS that were of A-$9.62.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.17-54.71%
2025A-$2.59-73.08%
2024A-$9.62-93.88%
2023A-$157.09-8.14%
2022A-$171.0192.67%
2021A-$88.76-80.33%
2020A-$451.19-35.11%
2019A-$695.27-38.96%
2018A-$1,139-6.1%
2017A-$1,21336.67%
2016A-$887.5833.33%
2015A-$665.6950%
2014A-$443.79-53.85%
2013A-$961.55-7.14%
2012A-$1,036-64.1%
2011A-$2,88577.27%
2010A-$1,627144.44%
2009A-$665.6912.93%
2008A-$589.4812.2%
2007A-$525.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.88-990.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
A-$0.77-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A-$9.91 793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$7.46 572.00%๐Ÿ‡บ๐Ÿ‡ธ USA